210 related articles for article (PubMed ID: 14695884)
1. Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization.
Aharoni A; Gaidukov L; Yagur S; Toker L; Silman I; Tawfik DS
Proc Natl Acad Sci U S A; 2004 Jan; 101(2):482-7. PubMed ID: 14695884
[TBL] [Abstract][Full Text] [Related]
2. Directed evolution of serum paraoxonase PON3 by family shuffling and ancestor/consensus mutagenesis, and its biochemical characterization.
Khersonsky O; Rosenblat M; Toker L; Yacobson S; Hugenmatter A; Silman I; Sussman JL; Aviram M; Tawfik DS
Biochemistry; 2009 Jul; 48(28):6644-54. PubMed ID: 19492856
[TBL] [Abstract][Full Text] [Related]
3. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes.
Harel M; Aharoni A; Gaidukov L; Brumshtein B; Khersonsky O; Meged R; Dvir H; Ravelli RB; McCarthy A; Toker L; Silman I; Sussman JL; Tawfik DS
Nat Struct Mol Biol; 2004 May; 11(5):412-9. PubMed ID: 15098021
[TBL] [Abstract][Full Text] [Related]
4. Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase.
Khersonsky O; Tawfik DS
Biochemistry; 2005 Apr; 44(16):6371-82. PubMed ID: 15835926
[TBL] [Abstract][Full Text] [Related]
5. Estrogen esters as substrates for human paraoxonases.
Teiber JF; Billecke SS; La Du BN; Draganov DI
Arch Biochem Biophys; 2007 May; 461(1):24-9. PubMed ID: 17412306
[TBL] [Abstract][Full Text] [Related]
6. Directed evolution of recombinant serum paraoxonase (PON) variants.
Aharoni A; Tawfik DS
Discov Med; 2004 Apr; 4(21):120-4. PubMed ID: 20705007
[TBL] [Abstract][Full Text] [Related]
7. Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.
Bajaj P; Tripathy RK; Aggarwal G; Pande AH
Protein Expr Purif; 2015 Nov; 115():95-101. PubMed ID: 26003526
[TBL] [Abstract][Full Text] [Related]
8. Altering the substrate specificity of organophosphorus hydrolase for enhanced hydrolysis of chlorpyrifos.
Cho CM; Mulchandani A; Chen W
Appl Environ Microbiol; 2004 Aug; 70(8):4681-5. PubMed ID: 15294802
[TBL] [Abstract][Full Text] [Related]
9. Directed evolution of sulfotransferases and paraoxonases by ancestral libraries.
Alcolombri U; Elias M; Tawfik DS
J Mol Biol; 2011 Aug; 411(4):837-53. PubMed ID: 21723874
[TBL] [Abstract][Full Text] [Related]
10. The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3.
Taler-Verčič A; Goličnik M; Bavec A
Molecules; 2020 Dec; 25(24):. PubMed ID: 33348669
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonases-1, -2 and -3: What are their functions?
Furlong CE; Marsillach J; Jarvik GP; Costa LG
Chem Biol Interact; 2016 Nov; 259(Pt B):51-62. PubMed ID: 27238723
[TBL] [Abstract][Full Text] [Related]
12. The evolutionary origins of detoxifying enzymes: the mammalian serum paraoxonases (PONs) relate to bacterial homoserine lactonases.
Bar-Rogovsky H; Hugenmatter A; Tawfik DS
J Biol Chem; 2013 Aug; 288(33):23914-27. PubMed ID: 23788644
[TBL] [Abstract][Full Text] [Related]
13. Identification of biologically active δ-lactone eicosanoids as paraoxonase substrates.
Teiber JF; Xiao J; Kramer GL; Ogawa S; Ebner C; Wolleb H; Carreira EM; Shih DM; Haley RW
Biochem Biophys Res Commun; 2018 Oct; 505(1):87-92. PubMed ID: 30241945
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
15. Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives.
Bajaj P; Tripathy RK; Aggarwal G; Pande AH
ScientificWorldJournal; 2014; 2014():854391. PubMed ID: 25386619
[TBL] [Abstract][Full Text] [Related]
16. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase.
Amitai G; Gaidukov L; Adani R; Yishay S; Yacov G; Kushnir M; Teitlboim S; Lindenbaum M; Bel P; Khersonsky O; Tawfik DS; Meshulam H
FEBS J; 2006 May; 273(9):1906-19. PubMed ID: 16640555
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonases (PON1, PON2, PON3) analyses in vitro and in vivo in relation to cardiovascular diseases.
Aviram M; Rosenblat M
Methods Mol Biol; 2008; 477():259-76. PubMed ID: 19082953
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of organophosphorus hydrolase variants with high degradation activity towards organophosphate pesticides.
Mee-Hie Cho C; Mulchandani A; Chen W
Protein Eng Des Sel; 2006 Mar; 19(3):99-105. PubMed ID: 16423845
[TBL] [Abstract][Full Text] [Related]
19. Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192.
Aggarwal G; Prajapati R; Tripathy RK; Bajaj P; Iyengar AR; Sangamwar AT; Pande AH
PLoS One; 2016; 11(2):e0147999. PubMed ID: 26829396
[TBL] [Abstract][Full Text] [Related]
20. 3-D structure of serum paraoxonase 1 sheds light on its activity, stability, solubility and crystallizability.
Harel M; Brumshtein B; Meged R; Dvir H; Ravelli RB; McCarthy A; Toker L; Silman I; Sussman JL
Arh Hig Rada Toksikol; 2007 Sep; 58(3):347-53. PubMed ID: 17913690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
